PRA Health initiated with a Peer Perform at Wolfe Research
Wolfe Research started PRA Health with a Peer Perform rating and $112 price target, stating that the firm is cautious on softening gross bookings in the second half of 2018 and the revenue ramp and margin improvement imbedded in guidance for 2019.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.